Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 p values from general linear models

From: Endothelial injury in rheumatoid arthritis: a crosstalk between dimethylarginines and systemic inflammation

  ADMA SDMA ADMA:SDMA
Factor Main Eff. Inflam. Int. Main Eff. Inflam. Int. Main Eff. Inflam. Int.
Log2ACh 0.390 0.954 0.636 0.008 0.030 0.014 0.007 0.093 0.027
Log2SNP 0.702 0.989 0.824 0.074 0.056 0.042 0.100 0.151 0.087
Log2FMD 0.363 0.767 0.677 0.420 0.097 0.092 0.174 0.138 0.110
Log2GTN 0.754 0.702 0.823 0.799 0.812 0.868 0.959 0.607 0.737
Log2cIMT 0.217 0.323 0.051 0.550 0.265 0.562 0.607 0.953 0.259
Log2SEVR 0.876 0.727 0.706 0.006 0.049 0.052 0.058 0.252 0.268
AIx (HR 75) 0.204 0.367 0.246 0.205 0.221 0.127 0.050 0.097 0.036
  1. p values from general linear models, with three terms included in each model: Main Eff. – the main effect of the factor being considered, Inflam. – a binary variable, stating whether a patient had high levels of inflammation (ESR > 25 and CRP > 5), Int. – an interaction term between Main Eff. and Inflam., testing whether the relationship between the factor and outcome differs by the degree of inflammation. Bold p values are significant at p < 0.05
  2. ADMA asymmetric dimethylarginine, SDMA symmetric dimethylarginine, ACh acetylcholine, SNP sodium nitroprusside, FMD flow-mediated dilatation, GTN glyceryl-trinitrate mediated dilatation, cIMT intima media thickness, SEVR subendocardial viability ratio, AIx augmentation index, HR heart rate